Blessed thistle, a plant commonly found in temperate climates, has long been used in herbal medicine for its digestive benefits. Now, researchers at the University of Cologne have uncovered a groundbreaking application for its extract, Cnicin.
Studies involving animal models and human cells have demonstrated that Cnicin possesses the remarkable ability to accelerate axon regeneration, the regrowth of nerve fibers. This is particularly significant for individuals suffering from nerve injuries, where the lengthy regeneration process often results in irreversible damage due to axons failing to reach their destinations in time.
Cnicin’s unique advantage lies in its oral administration, eliminating the need for injections. However, the correct dosage is crucial, as Cnicin’s effectiveness operates within a specific therapeutic window. Doses that fall outside this range prove ineffective.
The University of Cologne researchers are now planning clinical studies to further investigate the potential of Cnicin in humans. The Center for Pharmacology continues its research and development of drugs aimed at repairing damaged nervous systems, with this current study receiving funding from the Federal Ministry of Education and Research under the PARREGERON project.
